A Clinical Study to Assess the Efficacy of Weekly Doxycycline Prophylaxis to Reduce Bacterial Sexually Transmitted Infections (STI) in Young African Women

StatusNot Yet Recruiting
PhasePhase 3
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This study is for people who may get sexually transmitted infections (STIs). Approximately 580 African adolescent and young adult women ages 13-34 in Africa will be included in this study. Study participation is approximately 52 weeks (1 year). Participants will be randomized in a 1:1 ratio to receive doxycycline prophylaxis or standard of care.
Trial Details
NCT Number NCT07884240
Lead Sponsor National Institute of Allergy and Infectious Diseases (NIAID)
Conditions
(from sponsor)		 Sexually Transmitted Infection (STI), Gonorrhea, Syphilis, Chlamydia
Related terms Chlamydia Infections, Gonorrhea, Sexually Transmitted Diseases, Syphilis
Enrollment 580 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov